Happy to help you set this up — but to build something that's actually useful (rather than a generic template), I need to pin down a few things first. Lung cancer + imaging + "outcomes" is a huge design space, and the right pipeline looks very different depending on the answers.

## Questions I need answered before I can set up a real analysis

**1. What imaging modality and data?**
- CT (most common for lung cancer — screening or diagnostic)? PET/CT? Chest X-ray? Pathology slides (if you mean histology images rather than radiology)?
- Do you already have a dataset in hand (e.g., a folder of DICOMs with a clinical spreadsheet), or do you need me to help you find/acquire a public dataset?
- If you need a public dataset, are you looking for something like NLST (National Lung Screening Trial), NSCLC-Radiomics ("Lung1"), or a TCGA-LUAD/TCGA-LUSC imaging+genomics cohort? I don't want to guess which one fits your question — they differ a lot in size, label availability, and what "outcome" even means in each.

**2. What outcome are you actually trying to predict or analyze?**
"Outcomes" could mean any of these, and they require different cohorts, labels, and modeling approaches:
- Overall survival / time-to-death (needs follow-up time + event indicator — survival analysis, e.g., Cox model or deep learning survival models)
- Recurrence or progression-free survival
- Treatment response (e.g., RECIST response after chemo/radiation/immunotherapy)
- Malignancy risk / diagnosis (benign vs. malignant nodule classification — this is a *screening* question, not really an "outcomes" question)
- Histologic subtype or molecular subtype (e.g., EGFR mutation status) predicted from imaging — radiogenomics

**3. What's the unit of analysis?**
- Whole-image / whole-scan level, or do you have (or need) nodule/tumor segmentations?
- Do you have annotations already, or will segmentation be part of the pipeline (manual, semi-automatic, or an existing model)?

**4. What clinical/outcome data do you have alongside the images?**
- Survival times and vital status? Treatment records? Staging (TNM)? Smoking history? These need to be linked to the imaging by patient/case ID, and data quality here usually matters more than the imaging model.

**5. What's the analysis goal — descriptive or predictive?**
- Are you trying to build a predictive model (train/validation/test split, performance metrics), or run a more exploratory/statistical analysis (e.g., do radiomic features correlate with survival)?

**6. Resources**
- What compute do you have access to (local machine, HPC cluster, cloud, GPU availability)?
- Are you working in Python? Any existing environment/package constraints?

## What I can do once I have those answers

Depending on your answers, the pipeline will generally include:
1. **Data acquisition/organization** — pulling images and matching clinical/outcome data by patient ID
2. **Preprocessing** — DICOM-to-NIfTI conversion, resampling to consistent voxel spacing, intensity normalization (e.g., HU windowing for CT), and lung segmentation if needed
3. **Feature extraction** — either handcrafted radiomics (e.g., via PyRadiomics: shape, texture, intensity features from a segmented region) or deep-learning feature embeddings from a pretrained 3D CNN
4. **Outcome modeling** — depending on the outcome type:
   - Survival: Cox proportional hazards or a deep survival model (e.g., DeepSurv), evaluated with concordance index (C-index)
   - Classification: logistic regression / gradient boosting / CNN, evaluated with AUC, sensitivity/specificity
5. **Validation** — proper train/test or cross-validation split *at the patient level* (not the image level, to avoid leakage), and ideally external validation on a second cohort if available
6. **Interpretability** — feature importance, SHAP values, or saliency maps depending on the model type

## A note on caution here

I want to flag two things rather than gloss over them:
- I don't currently have specific, verified sample sizes, file counts, or version/checkpoint numbers for public lung cancer imaging datasets to give you — rather than state a number I'm not sure of, I'd rather have you tell me which dataset you're using (or confirm one with me) so I can look up or you can verify the actual current cohort size and access requirements (some of these require institutional/CITI training credentials, e.g., TCIA collections).
- Any "outcomes" claim from a model like this needs a held-out, ideally external, validation set before you trust it clinically or scientifically — I'd build that into the plan from the start rather than bolt it on later.

If you can answer even just questions 1, 2, and 4 above, I can put together a concrete, runnable starter notebook (data loading, preprocessing, feature extraction, and a baseline outcome model) tailored to your actual data rather than a generic placeholder.
